PALbociclib CoLlaborative Adjuvant Study

Skip to Content

Clinical Trial Details

PALbociclib CoLlaborative Adjuvant Study


PALbociclib CoLlaborative Adjuvant Study: A randomized phase III trial of Palbociclib with standard adjuvant endocrine therapy versus standard adjuvant endocrine therapy alone for hormone receptor positive (HR+) / human epidermal growth factor receptor 2 (HER2)-negative early breast cancer

IRB Protocol Number

Clinical Trial Categories

  • Breast Cancer
NH Oncology Hematology Clinical Research Dept. at 603-224-2556


  • Payson Center for Cancer Care
    250 Pleasant Street
    Concord, NH 03301
    Main: 603-230-6000